PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 16 analysts with an average price target of $54.6. This is a potential upside of $10.76 (24.54%) from yesterday's end of day stock price of $43.84.

PTC Therapeutics's activity chart (see below) currently has 139 price targets and 222 ratings on display. The stock rating distribution of PTCT is 36.67% HOLD, 44.44% BUY and 18.89% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.19% with an average time for these price targets to be met of 227.13 days.

Highest price target for PTCT is $76, Lowest price target is $30, average price target is $54.6.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 15-Jan-2025. First documented stock forecast 14-Feb-2014.

Currently out of the existing stock ratings of PTCT, 33 are a HOLD (36.67%), 40 are a BUY (44.44%), 17 are a SELL (18.89%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$76

$32.16 (73.36%)

$64

3 days ago
(15-Jan-2025)

5/16 (31.25%)

$33.42 (78.49%)

298

Hold

$67

$23.16 (52.83%)

$45

1 months 5 days ago
(13-Dec-2024)

9/10 (90%)

$19.28 (40.40%)

149

Sell

$42

$-1.84 (-4.20%)

$32

1 months 14 days ago
(04-Dec-2024)

6/7 (85.71%)

$-8.57 (-16.95%)

87

Sell

$32

$-11.84 (-27.01%)

$26

1 months 14 days ago
(04-Dec-2024)

1/9 (11.11%)

$-18.57 (-36.72%)

100

Hold

$63

$19.16 (43.70%)

$34

1 months 15 days ago
(03-Dec-2024)

20/24 (83.33%)

$11.83 (23.12%)

157

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 227.13 days on average for the stock forecasts to be realized with a an average price target met ratio 56.19

Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?

KRISTEN KLUSKA

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Kristen Kluska works at CANTOR FITZGERALD and has 19 price targets and 14 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with highest potential upside - $32.16

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Heather Behanna with lowest potential downside - -$31.84

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?